Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 517

1.

Choroidal metastasis from granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma: a case report.

Fukuda S, Fujiwara Y, Mishima H, Wakasa T, Hanamoto H, Inoue K, Kitani K, Ishikawa H, Tsujie M, Yukawa M, Okajima K, Ohta Y, Inoue M.

Clin Case Rep. 2017 Feb 23;5(4):419-424. doi: 10.1002/ccr3.853. eCollection 2017 Apr.

2.

Feasibility and Efficacy of Autologous Bone Marrow Aspirate Transplantation Combined with Human Parathyroid Hormone 1-34 Administration to Treat Osteonecrosis in a Rabbit Model.

Makihara T, Yoshioka T, Sugaya H, Aoto K, Wada H, Uemura K, Tanaka K, Akaogi H, Yamazaki M, Mishima H.

Bone Marrow Res. 2017;2017:2484689. doi: 10.1155/2017/2484689. Epub 2017 Mar 13.

3.
4.

Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone.

Hanmoto T, Tabuchi Y, Ikegame M, Kondo T, Kitamura KI, Endo M, Kobayashi I, Mishima H, Sekiguchi T, Urata M, Seki A, Yano S, Hattori A, Suzuki N.

Biomed Res. 2017;38(1):71-77. doi: 10.2220/biomedres.38.71.

5.

Analysis of clinical symptoms and ABCC6 mutations in 76 Japanese patients with pseudoxanthoma elasticum.

Iwanaga A, Okubo Y, Yozaki M, Koike Y, Kuwatsuka Y, Tomimura S, Yamamoto Y, Tamura H, Ikeda S, Maemura K, Tsuiki E, Kitaoka T, Endo Y, Mishima H, Yoshiura KI, Ogi T, Tanizaki H, Wataya-Kaneda M, Hattori T, Utani A.

J Dermatol. 2017 Feb 10. doi: 10.1111/1346-8138.13727. [Epub ahead of print]

PMID:
28186352
6.

Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction.

Ishikawa T, Ohno S, Murakami T, Yoshida K, Mishima H, Fukuoka T, Kimoto H, Sakamoto R, Ohkusa T, Aiba T, Nogami A, Sumitomo N, Shimizu W, Yoshiura KI, Horigome H, Horie M, Makita N.

Heart Rhythm. 2017 May;14(5):717-724. doi: 10.1016/j.hrthm.2017.01.020. Epub 2017 Jan 17.

PMID:
28104484
7.

Corrigendum: Ultra-sensitive droplet digital PCR for detecting a low-prevalence somatic GNAQ mutation in Sturge-Weber syndrome.

Uchiyama Y, Nakashima M, Watanabe S, Miyajima M, Taguri M, Miyatake S, Miyake N, Saitsu H, Mishima H, Kinoshita A, Arai H, Yoshiura KI, Matsumoto N.

Sci Rep. 2017 Jan 12;7:39897. doi: 10.1038/srep39897. No abstract available.

8.

Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.

Suto T, Ishiguro M, Hamada C, Kunieda K, Masuko H, Kondo K, Ishida H, Nishimura G, Sasaki K, Morita T, Hazama S, Maeda K, Mishima H, Ike H, Sadahiro S, Sugihara K, Okajima M, Saji S, Sakamoto J, Tomita N.

Int J Clin Oncol. 2017 Jan 11. doi: 10.1007/s10147-016-1083-9. [Epub ahead of print]

PMID:
28078540
9.

Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study).

Nakamura M, Aoyama T, Ishibashi K, Tsuji A, Takinishi Y, Shindo Y, Sakamoto J, Oba K, Mishima H.

Cancer Chemother Pharmacol. 2017 Jan;79(1):29-36. doi: 10.1007/s00280-016-3203-7. Epub 2016 Nov 22.

10.

Giant insulinoma: report of a case and review of published reports.

Ueda K, Taira T, Hakoda H, Nakata S, Okata S, Nagai T, Aoki S, Mishima H, Sako A, Maruyama T, Okumura M.

Surg Case Rep. 2016 Dec;2(1):136. Epub 2016 Nov 19.

11.

Pharmacokinetic dose adjustment of 5-FU in modified FOLFOX7 plus bevacizumab for metastatic colorectal cancer in Japanese patients: a-JUST phase II clinical trial.

Denda T, Kanda M, Morita Y, Kim HM, Kashiwada T, Matsuda C, Fujieda S, Nakata K, Murotani K, Oba K, Sakamoto J, Mishima H.

Cancer Chemother Pharmacol. 2016 Dec;78(6):1253-1261. Epub 2016 Nov 2.

PMID:
27807652
12.

New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.

Kuniyoshi K, Hayashi T, Sakuramoto H, Mishima H, Tsuneoka H, Tsunoda K, Iwata T, Shimomura Y.

Jpn J Ophthalmol. 2016 Nov;60(6):476-485. Epub 2016 Aug 13.

PMID:
27522502
13.

Regulatory Mechanism of Collagen Degradation by Keratocytes and Corneal Inflammation: The Role of Urokinase-Type Plasminogen Activator.

Sugioka K, Mishima H, Kodama A, Itahashi M, Fukuda M, Shimomura Y.

Cornea. 2016 Nov;35 Suppl 1:S59-S64. Review.

PMID:
27661072
14.

Primary gastrointestinal stromal tumor of the liver: a case report and review of the literature.

Nagai T, Ueda K, Hakoda H, Okata S, Nakata S, Taira T, Aoki S, Mishima H, Sako A, Maruyama T, Okumura M.

Surg Case Rep. 2016 Dec;2(1):87. doi: 10.1186/s40792-016-0218-6. Epub 2016 Sep 1.

15.

A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).

Hazama S, Maeda H, Iwamoto S, Kim HM, Takemoto H, Kobayashi K, Sakamoto J, Nagata N, Oba K, Mishima H.

Clin Colorectal Cancer. 2016 Dec;15(4):329-336. doi: 10.1016/j.clcc.2016.07.003. Epub 2016 Jul 18.

PMID:
27507128
16.

Seawater Polluted with Highly Concentrated Polycyclic Aromatic Hydrocarbons Suppresses Osteoblastic Activity in the Scales of Goldfish, Carassius auratus.

Suzuki N, Sato M, Nassar HF, Abdel-Gawad FKh, Bassem SM, Yachiguchi K, Tabuchi Y, Endo M, Sekiguchi T, Urata M, Hattori A, Mishima H, Shimasaki Y, Oshima Y, Hong CS, Makino F, Tang N, Toriba A, Hayakawa K.

Zoolog Sci. 2016 Aug;33(4):407-13. doi: 10.2108/zs150211.

PMID:
27498800
17.

Sodium fluoride induces hypercalcemia resulting from the upregulation of both osteoblastic and osteoclastic activities in goldfish, Carassius auratus.

Sato M, Hanmoto T, Yachiguchi K, Tabuchi Y, Kondo T, Endo M, Kitani Y, Sekiguchi T, Urata M, Hai TN, Srivastav AK, Mishima H, Hattori A, Suzuki N.

Comp Biochem Physiol C Toxicol Pharmacol. 2016 Nov;189:54-60. doi: 10.1016/j.cbpc.2016.07.006. Epub 2016 Jul 27.

PMID:
27475026
18.

2. The Effect of Combined Therapy, Percutaneous Autologous Concentrated Bone Marrow Grafting and Low-Intensity Pulsed Ultrasound (LIPUS), on the Treatment of Non-Unions.

Mishima H, Sugaya H, Yoshioka T, Wada H, Aoto K, Hyodo K, Tomaru Y, Kumagai H, Akaogi H, Ochiai N, Yamazaki M.

J Orthop Trauma. 2016 Aug;30(8):S2. doi: 10.1097/01.bot.0000489987.43355.1d.

PMID:
27441763
19.

Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX Trial.

Matsui T, Nagata N, Hirata K, Okazaki S, Sato S, Nakamura M, Kim H, Oba K, Sakamoto J, Mishima H.

Anticancer Res. 2016 Jul;36(7):3437-43.

PMID:
27354605
20.

Supplemental Content

Loading ...
Support Center